| Author, year (country) | Outcomes | Studies (participants, intervention group/control group) | Relative effect (95% CI) | Heterogeneity | value |
| Na Yang, 2021 (China) [18] | Effective rate | 7 (523, 264/259) | OR = 5.52 (3.13, 9.73) | I2 = 0% | | | 1-hour pad test | 5 (417, 210/207) | SMD = −2.67 (−4.05, −1.29) | I2 = 96% | | | ICIQ-SF score | 4 (366, 183/183) | MD = −3.46, (−3.69, −3.22) | I2 = 87% | | Xiuhua Lai, 2020 (China) [19] | Effective rate | 13 (1,333, 667/666) | OR = 5.64 (4.19, 7.59) | I2 = 22% | | | ICIQ-SF score | 6 (763, 381/382) | SMD = −0.61 (−0.74, −0.48) | I2 = 80% | | | 1-hour pad test | 5 (900, 450/450) | MD = −4.14 (−4.96, −3.33) | I2 = 78% | | Yajing Zhong, 2020 (China) [20] | Effective rate | 7 (1,010, 503/507) | RR = 2.03 (1.40, 2.95) | I2 = 89% | | | 1-hour pad test | 9 (1,157, 578/579) | MD = 3.33 (0.89, 5.77) | I2 = 98% | | | ICIQ-SF score | 9 (1,157, 578/579) | MD = 3.14 (2.42, 3.85) | I2 = 63% | | | 72-hour incontinence episodes | 3 (654, 327/327) | MD = 1.17 (0.56, 1.78) | I2 = 0% | | | Follow-up of the effective rate | 2 (584, 292/292) | MD = 2.10 (1.28, 2.92) | I2 = 0% | | | Follow-up of the ICIQ-SF score | 3 (644, 322/322) | MD = 2.89 (1.96, 3.82) | I2 = 54% | | | Follow-up of the 72-hour incontinence episodes | 2 (584, 292/292) | MD = 2.10 (1.28, 2.92) | I2 = 0% | | Chen, et al. 2018 (China) [21] | Effective rate (acupuncture and RT) | 8 (558, 281/277) | RR = 1.33 (1.22, 1.46) | I2 = 0% | | | Effective rate (acupuncture and CM) | 3 (220, 110/110) | RR = 2.15 (1.64, 2.83) | I2 = 0% | | | ICIQ-SF score (acupuncture and RT) | 5 (323, 162/161) | MD = −1.29 (−2.88, 0.31) | I2 = 80% | | Chen, 2020 (China) [22] | Effective rate | 7 (577, 289/287) | OR = 4.10 (1.85, 9.10) | I2 = 62% | | Ma, et al. 2021 (China) [23] | Effective rate | 13 (812, 408/404) | OR = 6.04 (3.84, 9.49) | I2 = 0% | | | ICIQ-SF score | 6 (377, 189/188) | MD = −3.03 (−4.17, −1.90) | I2 = 80% | | | 1-hour pad test | 9 (504, 252/252) | MD = −2.95 (−3.86, −2.04) | I2 = 88% | | | 24-hour urination diary | 9 (143, 71/72) | MD = −0.97 (−1.61, −0.33) | I2 = 65% | | Wang, et al. 2014 (China) [24] | Effective rate (acupuncture and RT) | 5 (461, 231/230) | OR = 4.00 (2.51, 6.39) | I2 = 0% | | | Effective rate (acupuncture and CM) | 3 (220, 110/110) | OR = 9.14 (4.77, 17.53) | I2 = 47% | | | Effective rate (acupuncture and placebo) | 2 (198, 99/99) | OR = 3.05 (1.59, 5.84) | I2 = 0% | | Zhang and Xie 2016 (China) [25] | Effective rate | 10 (785, 394/391) | OR = 4.27 (2.42, 7.56) | I2 = 50% | | | ICIQ-SF score | 4 (257, 129/128) | SMD = −0.41 (−1.00, 0.18) | I2 = 82% | | | VAS | 2 (206, 103/103) | SMD = −2.16 (−2.51, −1.81) | I2 = 0% | |
|
|